Similar articles

• Management of hypertension: pharmacotherapy.

  Campbell N, Chockalingam A. Campbell N, et al. Indian Heart J. 2005 Nov-Dec;57(6):644-7. Indian Heart J. 2005. PMID: 16521630 Review. No abstract available.
• Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.

  de Leeuw PW; Joint National Committee; World Health Organization - International Society of Hypertension. de Leeuw PW, et al. J Hypertens Suppl. 2001 Sep;19(3):S41-5. J Hypertens Suppl. 2001. PMID: 11713850 Review.
• Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.

  Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. Adigun AQ, et al. J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538. J Hum Hypertens. 2003. PMID: 12714973
• Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.

  Levine B. Levine B. Curr Med Res Opin. 2001;17(1):8-17. Curr Med Res Opin. 2001. PMID: 11464450 Clinical Trial.
• Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.

  Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Jamerson KA, et al. Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003. Am J Hypertens. 2004. PMID: 15177521 Clinical Trial.